These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9640778)

  • 1. [Exogenous gangliosides and Guillain-Barré syndrome].
    Orden AO; Presas JL
    Medicina (B Aires); 1997; 57(3):385-6. PubMed ID: 9640778
    [No Abstract]   [Full Text] [Related]  

  • 2. Gangliosides and Guillain-Barré syndrome. Science supports the use of gangliosides.
    Massarotti M; Matano R
    BMJ; 1994 Mar; 308(6929):654. PubMed ID: 8074748
    [No Abstract]   [Full Text] [Related]  

  • 3. Exogenous gangliosides and Guillain-Barré syndrome. An observational study in the local health district of Ferrara, Italy.
    Govoni V; Granieri E; Tola MR; Paolino E; Casetta I; Fainardi E; Monetti VC
    Brain; 1997 Jul; 120 ( Pt 7)():1123-30. PubMed ID: 9236625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome after exogenous gangliosides in Italy.
    Landi G; D'Alessandro R; Dossi BC; Ricci S; Simone IL; Ciccone A
    BMJ; 1993 Dec; 307(6917):1463-4. PubMed ID: 8281088
    [No Abstract]   [Full Text] [Related]  

  • 5. Exposure to exogenous gangliosides and Guillain-Barré syndrome.
    Beghi E
    Neuroepidemiology; 1995; 14(2):45-8. PubMed ID: 7891813
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relationship between parenteral gangliosides administration and the Guillain-Barré syndrome].
    Conceição I; Carvalho M; Alves M; Parreira E; Martins A; Ferro J; Sales-Luis ML
    Rev Neurol; 1999 Jun 1-15; 28(11):1033-5. PubMed ID: 10390766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gangliosides and the Guillain-Barré syndrome.
    Landi G; Ciccone A; D'Alessandro R; Dossi BC; Ricci S; Simone IL
    BMJ; 1994 Jun; 308(6944):1638. PubMed ID: 8025444
    [No Abstract]   [Full Text] [Related]  

  • 8. Gangliosides and Guillain-Barré syndrome. Apparent association is a coincidence.
    Grigoletto F
    BMJ; 1994 Mar; 308(6929):653-4. PubMed ID: 8148725
    [No Abstract]   [Full Text] [Related]  

  • 9. [Guillain-Barré syndrome. Clinical suspicion of adverse reaction to a drug].
    Toll J; Llorens MJ; Borrell F; Paredes I
    Med Clin (Barc); 1993 Sep; 101(7):275. PubMed ID: 7746005
    [No Abstract]   [Full Text] [Related]  

  • 10. Guillain-Barré syndrome and ganglioside therapy in Italy.
    Raschetti R; Maggini M; Popoli P
    Lancet; 1992 Jul; 340(8810):60. PubMed ID: 1351644
    [No Abstract]   [Full Text] [Related]  

  • 11. [Carbamazepine as a cause of Guillain-Barré syndrome?].
    Noring L
    Lakartidningen; 1985 May; 82(19):1778, 1780. PubMed ID: 3999884
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased circulating T cell reactivity to GM1 ganglioside in patients with Guillain-Barré syndrome.
    Csurhes PA; Sullivan AA; Green K; Greer JM; Pender MP; McCombe PA
    J Clin Neurosci; 2005 May; 12(4):409-15. PubMed ID: 15925771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disorder resembling Guillain-Barré syndrome on initiation of statin therapy.
    Rajabally YA; Varakantam V; Abbott RJ
    Muscle Nerve; 2004 Nov; 30(5):663-6. PubMed ID: 15389662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain Barré syndrome as a sequela of organophosphorus poisoning.
    Adlakha A; Philip PJ; Dhar KL
    J Assoc Physicians India; 1987 Sep; 35(9):665-6. PubMed ID: 3436940
    [No Abstract]   [Full Text] [Related]  

  • 16. [Guillain-Barre syndrome associated to treatment with gold salts].
    Bonaventura I; Martínez S; Martínez I; Aguilar M
    Rev Clin Esp; 1993 Nov; 193(7):405-6. PubMed ID: 7904766
    [No Abstract]   [Full Text] [Related]  

  • 17. Guillain Barre syndrome as a sequelae of organophosphate poisoning.
    Wadia RS
    J Assoc Physicians India; 1990 Feb; 38(2):187. PubMed ID: 2380144
    [No Abstract]   [Full Text] [Related]  

  • 18. Guillain Barre syndrome as a sequela of organophosphorus poisoning.
    Mishra VN; Raman PG
    J Assoc Physicians India; 1988 May; 36(5):347. PubMed ID: 3182700
    [No Abstract]   [Full Text] [Related]  

  • 19. Guillain-Barré syndrome following zimeldine treatment.
    Fagius J; Osterman PO; Sidén A; Wiholm BE
    J Neurol Neurosurg Psychiatry; 1985 Jan; 48(1):65-9. PubMed ID: 3156214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
    Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
    Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.